Sci Pharmtech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 12, 2019 at 01:42 pm EST
Share
SCI Pharmtech, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 627.814 million compared to TWD 519.414 million a year ago. Operating income was TWD 191.377 million compared to TWD 149.448 million a year ago. Net income was TWD 159.828 million compared to TWD 126.881 million a year ago. Basic earnings per share was TWD 2.01 compared to TWD 1.6 a year ago. Diluted earnings per share was TWD 2 compared to TWD 1.59 a year ago. For the nine months, sales was TWD 1,835.788 million compared to TWD 1,475.497 million a year ago. Operating income was TWD 573.288 million compared to TWD 387.151 million a year ago. Net income was TWD 481.603 million compared to TWD 336.972 million a year ago. Basic earnings per share was TWD 6.06 compared to TWD 4.24 a year ago. Diluted earnings per share was TWD 6 compared to TWD 4.21 a year ago.
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
SCI PHARMTECH, INC. 
